Literature DB >> 8625698

Azathioprine as a steroid-sparing agent in radiation pneumonitis.

M J McCarty1, P Lillis, S J Vukelja.   

Abstract

Radiation therapy is commonly used for treatment of neoplastic disease involving the thorax. Treatment complications include radiation pneumonitis that may require therapy with corticosteroids which possess significant side effects. We report the use of azathioprine as a steroid-sparing agent in a patient with severe radiation pneumonitis and steroid-induced myopathy.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8625698     DOI： 10.1378/chest.109.5.1397

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  11 in total

Review 1.  Radiation-Induced Lung Injury: Assessment and Management.

Authors:  Alexander N Hanania; Walker Mainwaring; Yohannes T Ghebre; Nicola A Hanania; Michelle Ludwig
Journal:  Chest       Date:  2019-04-15       Impact factor: 9.410

Review 2.  Interstitial lung disease in lung cancer: separating disease progression from treatment effects.

Authors:  Sarah Danson; Fiona Blackhall; Paul Hulse; Malcolm Ranson
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung).

Authors:  Victor Y Yazbeck; Liza Villaruz; Marsha Haley; Mark A Socinski
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

4.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

Review 5.  The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung.

Authors:  Florian Wirsdörfer; Verena Jendrossek
Journal:  Front Immunol       Date:  2016-12-14       Impact factor: 7.561

6.  Post-radiotherapy maintenance treatment with fluticasone propionate and salmeterol for lung cancer patients with grade III radiation pneumonitis: A case report.

Authors:  Pingping Zhang; Hongxia Yan; Sheng Wang; Jindan Kai; Guoliang Pi; Yi Peng; Xiyou Liu; Junwei Sun
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

Review 7.  The Role of Mesenchymal Stem Cells in Radiation-Induced Lung Fibrosis.

Authors:  Michele Zanoni; Michela Cortesi; Alice Zamagni; Anna Tesei
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

8.  Unexpected radiation pneumonitis after SIRT with significant decrease in DLCO with internal radiation exposure: a case report.

Authors:  Selin Kesim; Tunc Ones; Emel Eryuksel; Feyyaz Baltacioglu; Derya Tureli; Salih Ozguven; Tanju Yusuf Erdil
Journal:  BMC Med Imaging       Date:  2020-05-19       Impact factor: 1.930

9.  The Efficacy and Safety of Acupuncture for Preventing Radiation Pneumonitis in Patients With Lung Cancer: A Prospective, Single-Blinded, Randomized Pilot Proof-of-Principle Study.

Authors:  Moonkyoo Kong; Seung Hyeun Lee; Jaehyo Kim; Beom-Joon Lee; Kwan-Il Kim
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

10.  Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.

Authors:  C Henkenberens; S Janssen; M Lavae-Mokhtari; K Leni; A Meyer; H Christiansen; M Bremer; N Dickgreber
Journal:  Radiat Oncol       Date:  2016-02-02       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.